1ST Source Bank Invests $3.38 Million in HCA Healthcare, Inc. $HCA

Key Points

• 1ST Source Bank initiated a $3.38 million position in HCA Healthcare during the second quarter by purchasing 8,674 shares. Institutional investors and hedge funds collectively own 62.73% of the stock.
• Analysts maintain a generally positive outlook, with 14 Buy, eight Hold and one Sell rating. HCA has a “Moderate Buy” consensus rating and an average price target of $465.59.
• HCA exceeded quarterly expectations, reporting $7.59 in EPS and $20.23 billion in revenue, up 8.7% year over year. The company also declared a quarterly dividend of $0.78 per share, equal to a 0.8% annual yield.

1ST Source Bank bought a new position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 8,674 shares of the company's stock, valued at approximately $3,382,000.

A number of other institutional investors and hedge funds have also modified their holdings of HCA. Sumitomo Life Insurance Co. lifted its position in HCA Healthcare by 1.0% during the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company's stock worth $946,000 after acquiring an additional 20 shares during the last quarter. MJP Associates Inc. ADV boosted its stake in HCA Healthcare by 2.9% during the 4th quarter. MJP Associates Inc. ADV now owns 749 shares of the company's stock valued at $350,000 after purchasing an additional 21 shares during the period. Cary Street Partners Investment Advisory LLC boosted its position in shares of HCA Healthcare by 7.5% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company's stock valued at $140,000 after acquiring an additional 21 shares during the period. Anchyra Partners LLC raised its stake in HCA Healthcare by 3.7% during the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company's stock valued at $278,000 after purchasing an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd grew its position in HCA Healthcare by 0.6% in the 4th quarter. Plato Investment Management Ltd now owns 3,908 shares of the company's stock worth $1,833,000 after purchasing an additional 22 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on HCA shares. Raymond James Financial set a $528.00 price objective on shares of HCA Healthcare in a research report on Tuesday, July 7th. Deutsche Bank Aktiengesellschaft set a $476.00 price objective on HCA Healthcare in a research report on Monday, July 27th. Robert W. Baird lowered their price objective on HCA Healthcare from $396.00 to $393.00 and set a "neutral" rating on the stock in a research report on Monday, July 27th. Jefferies Financial Group set a $450.00 price target on shares of HCA Healthcare in a research note on Tuesday, July 14th. Finally, KeyCorp reduced their price objective on shares of HCA Healthcare from $475.00 to $435.00 and set an "overweight" rating for the company in a report on Monday, July 27th. Fourteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $465.59.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $404.61 on Monday. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52. The stock has a fifty day moving average price of $393.41 and a two-hundred day moving average price of $446.61. The firm has a market capitalization of $87.60 billion, a P/E ratio of 13.55, a P/E/G ratio of 1.40 and a beta of 1.10.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to analysts' expectations of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm's revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter last year, the company posted $6.84 EPS. On average, equities research analysts predict that HCA Healthcare, Inc. will post 29.47 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare's dividend payout ratio (DPR) is 10.45%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source